iSpecimen FY2023 revenue $9.93M (-4.5% YoY), net loss $11.1M; cash burn improves to $657K in Q4

iSpecimen Inc.

Revenue $9.93M vs $10.40M in 2022; specimen count fell 11% to 24,565 but ASP rose 7% to $404.
Net loss $11.10M ($1.23/sh) vs $10.2M ($1.16/sh); cash ended at $5.01M, down from $15.31M.
Q4 cash burn $657K, down from $4.29M in Q1; quote-to-PO conversion rose 39% vs prior quarters.
Record monthly revenue of ~$1.7M in Dec 2023; over 600 customer orgs and 7,428 registered users.
Entered ATM offering up to $1.5M on March 5, 2024 for additional funding.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

iSpecimen Inc. reported year ended December 31, 2023 results: net income net loss was approximately $11.10 million, EPS (1.23) per share.

Period: year ended December 31, 2023
Net income: net loss was approximately $11.10 million
EPS: (1.23) per share
Result: reported results

Exact text from the filing

For the year ended December 31, 2023, the net loss was approximately $11.10 million, or (1.23) per share, compared to a net loss of approximately $10.2 million, or $(1.16) per share, for the same period the prior year.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

iSpecimen Inc. reported twelve-month period ended December 31, 2023 results: revenue $9.93 million, net income $11.10 million net loss, EPS (1.23) per share.

Period: twelve-month period ended December 31, 2023
Revenue: $9.93 million
Net income: $11.10 million net loss
EPS: (1.23) per share
Result: reported results

Exact text from the filing

For the year ended December 31, 2023, revenue was approximately $9.93 million, compared to approximately $10.40 million for the year ended December 31, 2022.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-034321

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.